[Routine practice data collection for brexucabtagene autoleucel (MCL): Review of the study protocol (Version 4.0) and statistical analysis plan (Version 4.0) – Sixth Addendum to Project A21-130]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018014322
German
Original Title: Brexucabtagen Autoleucel (Mantelzelllymphom) - 6. Addendum zum Projekt A21-130 (AbD-Konzept)
Details
Project Status: Completed
Year Published: 2025
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Lymphoma, Mantle-Cell
  • Antigens, CD19
  • CD3 Complex
  • Receptors, Chimeric Antigen
  • Immunotherapy, Adoptive
  • Registries
Keywords
  • Brexucabtagene Autoleucel
  • Lymphoma – Mantle Cell
  • Registries
  • Benefit Assessment
  • Research Design
  • Peer Review – Research
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.